BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 24356250)

  • 1. Comprehensive overview of definitions for optical coherence tomography-based plaque and stent analyses.
    Di Vito L; Yoon JH; Kato K; Yonetsu T; Vergallo R; Costa M; Bezerra HG; Arbustini E; Narula J; Crea F; Prati F; Jang IK;
    Coron Artery Dis; 2014 Mar; 25(2):172-85. PubMed ID: 24356250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optical coherence tomography to evaluate coronary stent implantation and complications.
    Hayat U; Thondapu V; Ul Haq MA; Foin N; Jang IK; Barlis P
    Coron Artery Dis; 2015 Aug; 26 Suppl 1():e55-68. PubMed ID: 26247272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Impact of OCT Findings During PCI: The CLI-OPCI II Study.
    Prati F; Romagnoli E; Burzotta F; Limbruno U; Gatto L; La Manna A; Versaci F; Marco V; Di Vito L; Imola F; Paoletti G; Trani C; Tamburino C; Tavazzi L; Mintz GS
    JACC Cardiovasc Imaging; 2015 Nov; 8(11):1297-305. PubMed ID: 26563859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of long-term follow-up with neointimal coverage and stent apposition after sirolimus-eluting stent implantation by optical coherence tomography.
    Li S; Gai L; Yang T; Zhang L; Xu X; Bai Q; Xu H; Wang Y
    Catheter Cardiovasc Interv; 2013 Apr; 81(5):768-75. PubMed ID: 22639418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Initial findings of impact of strut width on stent coverage and apposition of sirolimus-eluting stents assessed by optical coherence tomography.
    Nakatani S; Nishino M; Taniike M; Makino N; Kato H; Egami Y; Shutta R; Tanouchi J; Yamada Y
    Catheter Cardiovasc Interv; 2013 Apr; 81(5):776-81. PubMed ID: 22517601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Edge vascular response after percutaneous coronary intervention: an intracoronary ultrasound and optical coherence tomography appraisal: from radioactive platforms to first- and second-generation drug-eluting stents and bioresorbable scaffolds.
    Gogas BD; Garcia-Garcia HM; Onuma Y; Muramatsu T; Farooq V; Bourantas CV; Serruys PW
    JACC Cardiovasc Interv; 2013 Mar; 6(3):211-21. PubMed ID: 23517830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neoatherosclerosis in Patients With Coronary Stent Thrombosis: Findings From Optical Coherence Tomography Imaging (A Report of the PRESTIGE Consortium).
    Joner M; Koppara T; Byrne RA; Castellanos MI; Lewerich J; Novotny J; Guagliumi G; Xhepa E; Adriaenssens T; Godschalk TC; Malik N; Alfonso F; Tada T; Neumann FJ; Desmet W; Ten Berg JM; Gershlick AH; Feldman LJ; Massberg S; Kastrati A;
    JACC Cardiovasc Interv; 2018 Jul; 11(14):1340-1350. PubMed ID: 30025727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal visualization of five different stent layers during and after percutaneous coronary intervention for recurrent in-stent restenosis using optical coherence tomography (OCT).
    Movahed MR; Ram V; Arsanjani R
    Cardiovasc Revasc Med; 2012; 13(5):292-4. PubMed ID: 22727600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serial assessment of vessel interactions after drug-eluting stent implantation in unprotected distal left main coronary artery disease using frequency-domain optical coherence tomography.
    Fujino Y; Attizzani GF; Bezerra HG; Wang W; Tahara S; Yamamoto H; Chamie D; Kanaya T; Mehanna E; Takagi K; Nakamura S; Costa MA
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1035-45. PubMed ID: 24156964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation and application of OCT tissue attenuation index for the detection of neointimal foam cells.
    Nicol P; Hoppman P; Euller K; Xhepa E; Lenz T; Rai H; Jinnouchi H; Bulin A; Castellanos MI; Lahmann AL; Koppara T; Kastrati A; Joner M
    Int J Cardiovasc Imaging; 2021 Jan; 37(1):25-35. PubMed ID: 32761285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two-week interval optical coherence tomography: imaging evidence on neointimal coverage completion after implantation of the Endeavor zotarolimus-eluting stent.
    Nishinari M; Shimohama T; Tojo T; Shiono T; Shinagawa H; Kameda R; Aoyama N; Izumi T
    Catheter Cardiovasc Interv; 2013 Dec; 82(7):E871-8. PubMed ID: 23873677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential Mechanisms of In-stent Neointimal Atherosclerotic Plaque Formation.
    Zhang DM; Chen SL
    J Cardiovasc Pharmacol; 2021 Sep; 78(3):388-393. PubMed ID: 34029271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multimodality visualization with 3-dimensional reconstruction of neointimal plaque rupture after bare-metal stent implantation.
    Sudo M; Hiro T; Takayama T; Iida K; Nishida T; Kawano T; Kanai T; Higuchi Y; Hirayama A
    JACC Cardiovasc Interv; 2014 Oct; 7(10):e163-5. PubMed ID: 25240542
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical and pathological characteristics of homogeneous and nonhomogeneous tissue of in-stent restenosis visualized by optical coherence tomography.
    Itoh T; Fusazaki T; Kimura T; Oikawa H; Sasou S; Ishikawa Y; Goto I; Komuro K; Nakajima S; Koeda Y; Kaneko K; Nishiyama O; Nakamura M; Morino Y
    Coron Artery Dis; 2015 May; 26(3):201-11. PubMed ID: 25714072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Impact of Suboptimal Stenting and Residual Intrastent Plaque/Thrombus Protrusion in Patients With Acute Coronary Syndrome: The CLI-OPCI ACS Substudy (Centro per la Lotta Contro L'Infarto-Optimization of Percutaneous Coronary Intervention in Acute Coronary Syndrome).
    Prati F; Romagnoli E; Gatto L; La Manna A; Burzotta F; Limbruno U; Versaci F; Fabbiocchi F; Di Giorgio A; Marco V; Ramazzotti V; Di Vito L; Trani C; Porto I; Boi A; Tavazzi L; Mintz GS
    Circ Cardiovasc Interv; 2016 Dec; 9(12):. PubMed ID: 27965297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcified Neoatherosclerosis Causing "Undilatable" In-Stent Restenosis: Insights of Optical Coherence Tomography and Role of Rotational Atherectomy.
    Bastante T; Rivero F; Cuesta J; Alfonso F
    JACC Cardiovasc Interv; 2015 Dec; 8(15):2039-2040. PubMed ID: 26738675
    [No Abstract]   [Full Text] [Related]  

  • 17. Optical coherence tomography characteristics of in-stent restenosis after drug-eluting stent implantation: a novel classification and its clinical significance.
    Yamamoto W; Fujii K; Otsuji S; Takiuchi S; Kakishita M; Ibuki M; Hasegawa K; Ishibuchi K; Tamaru H; Yasuda S; Ishii R; Nakabayashi S; Kusumoto H; Higashino Y
    Heart Vessels; 2020 Jan; 35(1):38-45. PubMed ID: 31250131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation in 3 months duration of neointimal coverage after zotarolimus-eluting stent implantation by optical coherence tomography: the ENDEAVOR OCT trial.
    Kim JS; Jang IK; Fan C; Kim TH; Kim JS; Park SM; Choi EY; Lee SH; Ko YG; Choi D; Hong MK; Jang Y
    JACC Cardiovasc Interv; 2009 Dec; 2(12):1240-7. PubMed ID: 20129551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Restenosis After Drug-Eluting Stent Implantation in a Patient With Polycythemia Vera: Optical Coherence Tomography and Pathological Findings.
    Fujino A; Hao H; Kajimoto N; Kawakami R; Imanaka T; Fujii K; Abe T; Ishihara M; Hirota S
    JACC Cardiovasc Interv; 2015 Jun; 8(7):e111-2. PubMed ID: 26003023
    [No Abstract]   [Full Text] [Related]  

  • 20. A prospective randomised study using optical coherence tomography to assess endothelial coverage and neointimal proliferation at 6-months after implantation of a coronary everolimus-eluting stent compared with a bare metal stent postdilated with a paclitaxel-eluting balloon (OCTOPUS Trial): rationale, design and methods.
    Poerner TC; Otto S; Gassdorf J; Janiak F; Danzer C; Ferrari M; Figulla HR
    EuroIntervention; 2011 May; 7 Suppl K():K93-9. PubMed ID: 22027737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.